Destaques
Ainda tossindo depois da COVID? Estas são as razões para isso e o que fazer a respeito.
1 Abr, 2022 | 13:10hStill coughing after COVID? Here’s why it happens and what to do about it – The Conversation
Ponto de vista | Avaliação da efetividade dos testes diagnósticos.
1 Abr, 2022 | 13:09hEvaluating the Effectiveness of Diagnostic Tests – JAMA (gratuito por tempo limitado)
Estudo randomizado | Tratamento combinado de amisulprida e olanzapina vs. cada um em monoterapia para pacientes esquizofrênicos e agudamente doentes.
1 Abr, 2022 | 13:07hAmisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial – The Lancet Psychiatry (link para o resumo – $ para o texto completo)
Comentário no Twitter
RCT: At 8 weeks, PANSS total score improved more with amisulpride + olanzapine (−29·6) than with olanzapine + placebo (−24·1, p=0·049, d=0·396), but not vs. amisulpride + placebo (−25·2, p=0·095, d=0·29) in acutely ill patients with schizophrenia https://t.co/Se75PJ3a0N
— PfOL (@psychopharmacol) March 18, 2022
Recomendações da OMS sobre o cuidado com a mãe e recém-nascido para uma experiência pós-natal positiva.
1 Abr, 2022 | 12:37hComunicado de imprensa: WHO urges quality care for women and newborns in critical first weeks after childbirth – World Health Organization
Comentário: Postnatal care: WHO highlights urgency of physical and mental support – The BMJ
Estratégia de vigilância genômica global da OMS para patógenos com potencial pandêmico e epidêmico 2022-2032.
1 Abr, 2022 | 12:36hComunicado de imprensa: WHO releases 10-year strategy for genomic surveillance of pathogens – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
🆕 Today @WHO published the Global Genomic Surveillance Strategy for Pathogens with Pandemic and Epidemic Potential (2022–2032)
Ambitious, comprehensive, strategic and necessary.
Short thread ⬇️https://t.co/98NMgMhbL6
— Maria Van Kerkhove (@mvankerkhove) March 30, 2022
Diretriz preliminar de recomendação da USPSTF | A evidência atual é insuficiente para recomendar rastreamento para apneia obstrutiva do sono em indivíduos assintomáticos.
1 Abr, 2022 | 12:34hComentário: USPSTF: Evidence Lacking for OSA Screening in Asymptomatic Adults – HealthDay
Estudo randomizado | Tratamento precoce com ivermectina não melhora os desfechos em pacientes com Covid-19.
1 Abr, 2022 | 12:33hComentário: Ivermectin does not prevent COVID-19 hospitalization, a new study says – NPR
Comentário no Twitter
Ivermectin: the largest randomized, double-blind trial yet conducted, with early treatment, indicates there is no difference compared with placebo. It doesn't work. Period. https://t.co/wiFygjRgkk
just published @NEJM pic.twitter.com/uZ0mMZnO0E— Eric Topol (@EricTopol) March 30, 2022
Estudo randomizado | Tratamento precoce de pacientes ambulatoriais com plasma convalescente reduz o risco de internação para pacientes com Covid-19.
1 Abr, 2022 | 12:30hEarly Outpatient Treatment for Covid-19 with Convalescent Plasma – New England Journal of Medicine
Comentários:
Early Use of High-Titer Plasma Reduced COVID Hospitalizations— Randomized trial that influenced indication shows benefits in a mostly unvaccinated population – MedPage Today (necessário cadastro gratuito)
Comentário no Twitter
Fewer recipients of convalescent plasma had progression of Covid-19–associated illness leading to hospitalization. https://t.co/joa9ajpAcd pic.twitter.com/mHTnEHYN2O
— NEJM (@NEJM) March 30, 2022
Estudo de caso-controle | Em crianças de 5 a 11 anos de idade, a vacina da Pfizer mostrou efetividade de 68% contra internação causada pela variante Ômicron.
1 Abr, 2022 | 12:29hComentário: COVID vaccination of children age 5-11 cut omicron hospitalizations by 68% – Children’s Hospital Boston
Conteúdo relacionado: [Preprint] Study shows significantly reduced effectiveness of the Pfizer vaccine in children 5 to 11 after the emergency of the Omicron variant.
Comentário no Twitter
BNT162b2 vaccination reduced the risk of omicron-associated hospitalization by two thirds among children 5 to 11 years of age. https://t.co/mQcchQqbtH pic.twitter.com/Qzy8qKg1wC
— NEJM (@NEJM) March 30, 2022
Estudo randomizado | Mini-slings de incisão única para incontinência urinária de esforço em mulheres.
1 Abr, 2022 | 12:27hSingle-Incision Mini-Slings for Stress Urinary Incontinence in Women – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: Single-incision mini-slings effective for stress urinary incontinence in women – Healio (necessário cadastro gratuito)
Comentário no Twitter
For stress urinary incontinence in women, mini-slings were noninferior to midurethral slings with respect to patient-reported success at 15 months. https://t.co/Ag5p2u2WZW pic.twitter.com/PcajqXTiLW
— NEJM (@NEJM) March 30, 2022